Naphazoline Hydrochloride; Pheniramine Maleate

Drug Usage Statistics, United States, 2007 - 2017

Number of Prescriptions Over Time (2007 - 2017)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2007 224  10
2009 257 -
2010 379  122
2012 548 -
Year Rank Change
2013 304  244
2014 238  66
2015 208  30
2016 206  2
2017 203  3

Patient Out-Of-Pocket Cost Over Time (2007 - 2017)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Naphazoline Hydrochloride And Pheniramine Maleate
  • Naphcon-a
  • Opcon-a
  • Visine
Generic Drug Synonyms and Salts
  • Naphazoline Hydrochloride; Pheniramine Maleate

FDA Approval Information

Established Pharmacologic Class (EPC): N/A
Initial FDA approval date: 6/8/1994
First FDA applicant: Otc
First dosage form: Solution/Drops (ophthalmic)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007-2017. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 20.1. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

RxHero - Complete quests, earn points ... Develop rock-solid drug therapy knowledge
 
©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top